Brad Wilken is deputy director for business development and licensing for the Bill & Melinda Gates Foundation, where he covers the foundation’s Global Health portfolio. In this role, he oversees work with the foundation’s Program Strategy Teams to identify and evaluate potential strategic business partners and licensing opportunities that will help execute and advance the PST strategies. Among his accomplishments are leading the COVID-19 Therapeutics Accelerator and establishing the Gates Medical Research Institute.
Before joining the foundation, Brad spent nearly two decades working in the pharmaceutical and biotechnology industries for Regeneron Pharmaceuticals, Genentech and Eli Lilly. He held senior positions in project management and clinical operations.
Brad earned a Master of Public Health from Columbia University, a Master of Business Administration from Butler University and a Bachelor of Science in human biology from the University of Kansas.